Moving beyond Treg cells, a xenograft model of ASCT has found that inhibitory receptor expression on CD8+ T cells as well as downregulation of the costimulatory receptor CD226 (DNAM-1) were also associated with MM progression (47). This evidence concerns the gene CD226 and Miyoshi myopathy.